CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Attend An Event
State of the Science Summit
Regional Seminar Series
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
<< View More Conferences
2018 Lynn Sage Breast Cancer Symposium
Oncology Conference Multimedia
View more videos >>
Dr. Cristofanilli Discusses Roles of a Multidisciplinary Team in Breast Cancer
Dr. Sledge on Genomic Sequencing in Patients With Breast Cancer
Dr. Ruddy on the Importance of Genetic Testing in Breast Cancer
Oncology Conference Articles
Molecular Profiling in Metastatic Breast Cancer: Not Yet Standard of Care, But May Be in Near Future
As the cost of sequencing continues to fall, genomic testing will likely become widespread in all types of metastatic cancer, including breast cancer.
Gradishar Addresses 20 Years of Breast Cancer Advancements
William J. Gradishar, MD, discusses how far the breast cancer field has advanced over the last 20 years and the data he is anticipating to read out in the future.
Predictive Value Examined Among Genomic Tests for Breast Cancer
Multiple gene signature assays have been developed that supply prognostic information for decisions on adjuvant chemotherapy and whether therapy should be of extended duration.
Progress Emerging With Optimal Adjuvant Therapy in Young Women With Breast Cancer
Determining the optimal adjuvant therapy in young women with breast cancer remains challenging, but some clarity is beginning to emerge.
Challenges Remain in Treating Patients With Phyllodes Breast Tumors
Andrea V. Barrio, MD, discusses the challenges with phyllodes tumors of the breast and how to manage this disease moving forward.
Conventional View May Not Apply for All Triple-Negative Breast Cancers
All triple-negative breast cancers are not created equal, and clinicians should consider their inherent heterogeneity during diagnosis and treatment planning.
Expert Highlights Management of Locoregional Recurrence in Breast Cancer
Monica Morrow, MD, addresses how she treats patients with breast cancer who have locoregional recurrence and how therapeutic approaches have evolved over recent years.
Emerging Role of TILs in Breast Cancer Leads to Expanding Pathology Practices
Just as immunotherapies are transforming clinical practice for oncologists, these new therapies are also changing the practice of pathology and offering new ways for oncologists and pathologists to collaborate and improve patient care.
Expanded FDA Clearances Speed Scalp Cooling Acceptance in Oncology Community
Scalp cooling to limit alopecia in patients with cancer who are receiving chemotherapy is edging closer to becoming a widespread patient offering following recent FDA clearances.
Molecular Testing, Immunotherapy To Be Highlighted at 20th Annual Breast Cancer Conference
Advances in subtype-specific treatments, immunotherapy, ongoing issues with younger patients, the optimal use of neoadjuvant and adjuvant regimens, and molecular testing will be discussed at the 20th Annual Lynn Sage Breast Cancer Symposium.
FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More
PARP Inhibitors Hold Promise in mCRPC and Biallelic DNA Repair Gene Defects
Novel Agents Spark New Approaches for Triple-Negative Breast Cancer
Pembrolizumab/Cabozantinib Combo Is Well Tolerated, Shows Activity in Metastatic RCC
Pembrolizumab Shows Promising Activity in Non-Clear Cell RCC
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.